A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Obesity medications promise transformative care, but financial and systemic barriers limit access for those most in need.

On the latest episode of her podcast, Oprah Winfrey opened up about how her opinion of “thin people” changed after she was able to lose weight herself with the help of weight loss medications.

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...

As weight loss medications like Ozempic and Wegovy become increasingly popular, questions arise about whether the nation is approaching pea ...